Marianela Perez-Torres to Female
This is a "connection" page, showing publications Marianela Perez-Torres has written about Female.
Connection Strength
0.043
-
Perez-Torres M, Guix M, Gonzalez A, Arteaga CL. Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations. J Biol Chem. 2006 Dec 29; 281(52):40183-92.
Score: 0.019
-
Claudio-Campos K, Hern?ndez-Rivera J, Rivera-Gutierrez J, Ortiz-Rivera I, Carvajal-V?lez A, P?rez-Torres M, Pag?n-Ortiz M, Ospina-Mill?n CA. Biological screening of select Puerto Rican plants for cytotoxic and antitumor activities. P R Health Sci J. 2015 Mar; 34(1):25-30.
Score: 0.009
-
Miller TW, P?rez-Torres M, Narasanna A, Guix M, St?l O, P?rez-Tenorio G, Gonzalez-Angulo AM, Hennessy BT, Mills GB, Kennedy JP, Lindsley CW, Arteaga CL. Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. Cancer Res. 2009 May 15; 69(10):4192-201.
Score: 0.006
-
Ritter CA, Perez-Torres M, Rinehart C, Guix M, Dugger T, Engelman JA, Arteaga CL. Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network. Clin Cancer Res. 2007 Aug 15; 13(16):4909-19.
Score: 0.005
-
Wang SE, Narasanna A, Perez-Torres M, Xiang B, Wu FY, Yang S, Carpenter G, Gazdar AF, Muthuswamy SK, Arteaga CL. HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell. 2006 Jul; 10(1):25-38.
Score: 0.005